Profile data is unavailable for this security.
About the company
Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence and Critical Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes. Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.
- Revenue in GBP (TTM)1.75bn
- Net income in GBP121.72m
- Incorporated2016
- Employees10.13k
- LocationConvaTec Group PLC7th Floor, 20 Eastbourne TerraceLONDON W2 6LGUnited KingdomGBR
- Websitehttps://www.convatecgroup.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Ambu A/S | 601.39m | 26.22m |
Getinge AB | 2.41bn | 121.44m |
SCHOTT Pharma AG & Co KgaA | 789.23m | 125.15m |
Sectra AB | 130.00m | 32.12m |
Carl Zeiss Meditec AG | 1.72bn | 169.07m |
Ypsomed Holding AG | 552.80m | 66.64m |
Amplifon SpA | 1.96bn | 129.70m |
ConvaTec Group PLC | 1.75bn | 121.72m |
DiaSorin SpA | -83.20bn | -83.20bn |
Demant A/S | 2.50bn | 295.40m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Black Creek Investment Management, Inc.as of 01 Nov 2024 | 102.88m | 5.02% |
Artisan Partners LPas of 31 Dec 2022 | 97.98m | 4.78% |
Capital Research & Management Co. (Global Investors)as of 31 Dec 2022 | 97.42m | 4.75% |
FIL Investment Advisors (UK) Ltd.as of 30 Jul 2024 | 77.20m | 3.77% |
Schroder Investment Management Ltd.as of 01 Oct 2024 | 57.63m | 2.81% |
The Vanguard Group, Inc.as of 01 Oct 2024 | 55.92m | 2.73% |
FIL Investments Internationalas of 01 Oct 2024 | 53.76m | 2.62% |
Massachusetts Financial Services Co.as of 01 Oct 2024 | 44.96m | 2.19% |
abrdn Investment Management Ltd.as of 31 Dec 2022 | 43.37m | 2.12% |
Royal London Asset Management Ltd.as of 01 Oct 2024 | 41.17m | 2.01% |